Today: 24 January 2026
Subscribe
Browse Category

NYSE:NEE News 24 January 2026

Utilities stocks brace for Fed week as XLU slides and yields stay high

Utilities stocks brace for Fed week as XLU slides and yields stay high

New York, Jan 24, 2026, 13:36 EST — Market closed. U.S. utilities stocks ended the week under pressure, with the Utilities Select Sector SPDR ETF (XLU) slipping to $42.56 on Friday, down 0.35% for the day and roughly 2% lower on the week. XLU, which follows a group of S&P 500 utilities, often serves as a go-to gauge for the…
24 January 2026
········

Stock Market Today

  • BioCryst Pharmaceuticals (BCRX) Shares Under Pressure Amid Rare Disease Pipeline Focus
    January 24, 2026, 5:24 PM EST. BioCryst Pharmaceuticals (BCRX) shares have declined roughly 12% over one month, reflecting investor caution despite a 9.47% year-to-date return. Trading at $6.79, the stock sits well below its estimated fair value of $20.50. Revenue stands at $599.8 million, with a recent net loss of $8.8 million. The company's rare disease therapy, ORLADEYO, anchors its pipeline but reliance on this product and early-stage assets pose risks. Market expectations for growth hinge on operational leverage from BioCryst's scalable commercial platform and potential consolidation of rare disease assets amid biotech M&A. Investors should weigh these factors carefully before positioning in BCRX.
Go toTop